Juravinski Cancer Centre - McMaster University

699 Concession Street
Hamilton, Ontario L8V 5C2

We've found

1 trials

at this facility

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Status: Enrolling, Phase I, II
Updated: 7/25/2017

from

Hamilton,

Use our guide to learn which trials are right for you!